All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Efficacy of Trimebutine Maleate Combined With Hyperbaric Oxygen Therapy on Irritable Bowel Syndrome

Author(s): Xinli Feng, Yamei Wang, Ying Chang, Chuhai Wang, Juan Ji, Quanwei Di And Meng Sun*
Department of Hyperbaric Oxygen, 1Department of Infection Control, 2Department of Gastroenterology, 3Department of Neurology, 4Department of Nephrology, 5Department of Internal Medicine, Worker's Hospital of China Lucky Group Corporation, 6Department of Interventional Vascular Medicine, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, China

Correspondence Address:
Meng Sun, Department of Interventional Vascular Medicine, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, China, E-mail: sunmeng135135@sina.com


To determine the efficacy of trimebutine maleate combined with hyperbaric oxygen therapy on irritable bowel syndrome. Totally 180 patients diagnosed as irritable bowel syndrome who were admitted to our hospital between June 2016 and June 2019 were enrolled and randomized into the control group and the observation group according to the number of visits (each n=90). The control group was treated with trimebutine maleate through oral medication, while the observation group was given hyperbaric oxygen therapy additionally based on the treatment for the control group. Both groups were treated for 4 w. Then the following items of the two groups before and after intervention were evaluated and compared: serum neurotransmitterassociated parameters (5-hydroxytryptamine, somatostatin, substance P, neuropeptide Y), rectal manometry parameters (rectal sensation threshold, rectal defecation threshold, rectal pain threshold and rectal motor index), self-rating anxiety scale score and efficacy. Before treatment, no notable difference was found between the two groups in rectal manometry indices, serum neurotransmitter-associated indices and self-rating anxiety scale score (all p>0.05). After treatment, the rectal manometry indices, serum neurotransmitter-associated indices and self-rating anxiety scale score of both groups were greatly improved (all p<0.05) and all these improvements in the observation group were more significant than those in the control group (all p<0.05). In addition, the observation group got notably higher efficacy than the control group (p<0.01). Trimebutine maleate combined with hyperbaric oxygen therapy is effective in the therapy of irritable bowel syndrome, without toxic and side effects, so it is worthy of clinical application.

Full-Text | PDF

 
 
Google scholar citation report
Citations : 69022

Indian Journal of Pharmaceutical Sciences received 69022 citations as per google scholar report